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Spiked human urineAbstract A new spectrophotometric method which is simple, sensitive, selective and rapid is
described for the determination of metoclopramide hydrochloride (MCP) in bulk drug and in dos-
age forms using vanillin as the chromogenic agent. The method is based on the condensation reac-
tion between primary aromatic amine group present in MCP with aromatic aldehyde, vanillin to
produce an intense yellow colored product. The resulting Schiff’s base shows an absorption maxi-
mum at 410 nm and the reaction product is stable for more than one day. The reaction was carried
out in acetic acid and perchloric acid medium. Beer’s law was obeyed in the concentration range
1.5–15.0 lg ml1 MCP with a molar absorptivity of 1.89 · 104 l mol1 cm1. The limit of detection
(LOD) and limit of quantiﬁcation (LOQ) were found to be 0.51 and 1.55 lg ml1, respectively. The
method was statistically evaluated by calculating percent relative error (% RE) for accuracy and
percent relative standard deviation (% RSD) for precision, and was applied successfully to the
determination of MCP in tablets, in injection and also in spiked human urine. No interference
was observed from common additives found in pharmaceutical preparations. The results obtained
by the proposed method were validated statistically by comparing the results with those of the ref-
erence method by applying the Student’s t-test and F-test. The accuracy and reliability of the
method were further ascertained by performing recovery tests via standard-addition technique.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Metoclopramide hydrochloride, 4-amino-5-chloro-2-methoxy-
N-(2-diethylamino-ethyl) hydrochloride, is a dopamine-
receptor antagonist. It is a substituted benzamide used for its
prokinetic and antiemetic properties in disorders of decreased
gastrointestinal motility such as gastroparesis and ileus, as well
as in gastroesophageal reﬂux disease, dyspepsis, nausea and
vomiting, and for the prevention of cancer therapy-induced
emesis (American Hospital Formulary Service, 1989). It is
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Pharmacopoeia (2007) which recommend acid-base titrations
with potentiometric end point detection.
The wide use of MCP has prompted the development of
several analytical methods for its determination in pharmaceu-
ticals when present alone or in combination with other drugs
and include HPLC (Aqeel and Gregory, 1989; Besner et al.,
1989; Chang et al., 2000; Nagwa, 1994; Aboul-Enein and Raf-
iqul, 1990; Suleiman et al., 1989; Tian et al., 2009), LC–MS
(Yan et al., 2010), NMR spectrometry (Hanna and
Lau-Cam, 1991) differential scanning calorimetry and X-ray
powder diffractometry (Pabon et al., 1996), voltammetry (Far-
ghaly et al., 2005; Wang et al., 2001), potentiometry (Badwan
et al., 1986; Cannelo et al., 1989; Farnoush et al., 2009; Metr-
ohm Application Bulletin, 2001; Mostafa, 2003), ﬂow-injection
chemiluminescence spectrometry (Bao-xiu et al., 2010; Hun
and Zhang, 2008; Nawal, 2004; Shunli et al., 2002), ﬂuorimetry
(Attia and Aboaly, 2010; Buna et al., 1996), UV-spectropho-
tometry (Dudhane et al., 2010; Groszkowski et al., 1984a,b;
Wadher et al., 2008) and ﬂow-injection spectrophotometry
(Guo et al., 2009; Jing et al., 2005; Leda de Souza et al.,
2007; Royo Herrero et al., 1998). Some analytical techniques
have also been reported for the determination of MCP in bio-
logical matrices and include HPLC (Takahashi et al., 1987;
Mahasen, 1998; Fiorenzo et al., 1987; Brenda and Janis,
1990), LC–MS (Jaswanth et al., 2010), voltammetry (Farghaly
et al., 2005), potentiometry (Farnoush et al., 2009), ﬂow-injec-
tion chemiluminescence spectrometry (Nawal, 2004) and ﬂuo-
rimetry (Attia and Aboaly, 2010; Buna et al., 1996). Although
the above methods are sensitive, they are time-consuming and
complicated and require expensive instrumental set up.
Despite the availability of sophisticated and sensitive
instruments for the assay of MCP, visible spectrophotometry
continues to be the technique of choice in many laboratories,
particularly in developing and underdeveloped nations,
because of its simplicity, cost effectiveness, sensitivity and
selectivity, and fair accuracy and precision. Many visible spec-
trophotometric methods based on different reaction schemes
are found in the literature for the assay of MCP, especially
for the analysis of pharmaceutical preparations. Methods
based on redox reactions and using reagents such as sodium
vanadate (Ramappa and Shivakumara, 1990), ammonium
metavanadate (Singh et al., 1990) and Folin-Ciocalteu (Rao
et al., 1990) have been reported. Ahmad El-Gendy (1992)
has reported charge-transfer complex formation reaction using
chloranil or bromanil as p acceptors. There are two reports
based on ion-pair complex formation reaction of MCP with
bromothymol blue (Shingbal and Velingkar, 1988) and Mo
(V) and Co (II) thiocyanates (Fatma Abdel-Gawad and
Nabawia El-Guindi, 1995). Shingbal and Kudchadkar (1987)
have reported a method based on condensation reaction with
sodium 1,2-naphthoquinone-4-sulfonate to form a orange-red
colored product in the presence of borax. Methods based on
coupling reaction with reagents like 8-anilino-1-naphthalene
sulfonic acid, resorcinol and b-naphthol (Zarapkar and
Mehra, 1989); and 1–2 napthoquinone, hydroquinone and res-
orcinol (Zarapkar and Deshmukh, 1990) have also been re-
ported. The most widely used reaction for the assay of MCP
in pharmaceuticals has been the diazo-coupling reaction and
based on this reaction several workers have reported methods
using different reagents like imipramine hydrochloride
(Revanasiddappa and Veena, 2006), benzoyl acetone (Omran,2005), sodium nitrite and aniline (Shah et al., 2005), dibenzoyl
methane (Revanasiddappa and Manju, 2001), acetyl acetone
(Revanasiddappa and Manju, 2002), chromotropic acid
(Ramappa et al., 1999), 3-a, c-dicarboxypropylrhodanine
(Kalaschnikov et al., 1997), resorcinol (Shingbal and Joshi,
1984), 4-aminosalicylic acid (Emmanuel and Naik, 1983) and
sodium nitrite and b-napthol (Patel et al., 2006) . Other color
forming reactions such as oxidative coupling of MCP with
MBTH and cerium (IV) (Ramappa et al., 1999), Schiff base
formation with 4-dimethyl amino-benzaldehyde (Patel et al.,
2006), p-dimethylaminocinnamaldehyde (Moussa, 2000) have
also been reported.
However, most of the reported visible spectrophotometric
methods suffer from one or the other disadvantage like poor
sensitivity (Ramappa and Shivakumara, 1995; Singh et al.,
1990; Shingbal and Kudchadkar, 1987; Ahmad El-Gendy,
1992; Fatma Abdel-Gawad and Nabawia El-Guindi, 1995;
Zarapkar and Mehra, 1989; Revanasiddappa and Manju,
2002; Ramappa et al., 1999; Kalaschnikov et al., 1997; Mous-
sa, 2000), drastic experimental conditions like heating
(Ramappa and Shivakumara, 1995; Singh et al., 1990; Shing-
bal and Kudchadkar, 1987; Ahmad El-Gendy, 1992; Shah
et al., 2005), strict pH control (Shingbal and Velingkar,
1988; Omran, 2005), liquid-liquid extraction step (Shingbal
and Velingkar, 1988; Fatma Abdel-Gawad and Nabawia El-
Guindi, 1995), use of organic solvents (Shingbal and Veling-
kar, 1988; Fatma Abdel-Gawad and Nabawia El-Guindi,
1995; Omran, 2005; Revanasiddappa and Manju, 2001), nar-
row linear range (Zarapkar and Mehra, 1989; Zarapkar and
Deshmukh, 1990; Shingbal and Joshi, 1984; Moussa, 2000) etc.
The objective of this investigation was to devise simple, ra-
pid, sensitive and economically viable spectrophotometric
method that could be used to determine MCP in tablets, injec-
tion and spiked human urine. The determination involves the
Schiff’s base formation between MCP and vanillin in acid
medium, the product of the chemical association of an alde-
hyde with aromatic primary amine group was present in
MCP. The proposed method has been demonstrated to be
superior to the reported methods with respect to speed, sim-
plicity, sensitivity, selectivity and cost-effectiveness.2. Experimental
2.1. Apparatus
A Systronics model 106 digital spectrophotometer (Ahmeda-
bad, India) equipped with 1-cm matched quartz cells was used
to measure the absorbance readings.
2.2. Materials and reagents
All chemicals used were of analytical-reagent grade. MCP cer-
tiﬁed to be 99.74% was obtained as gift from IPCA Laborato-
ries Ltd., Mumbai, India. Vanillin was purchased from Loba
Chemie, Mumbai, India. Acetic acid and perchloric acid were
of analytical-reagent grade and they were purchased from
Merck, Mumbai, India.
Two brands of tablets containing 10 mg MCP per tablet,
Perinorm-10 (IPCA Laboratories Ltd., Mumbai, India) and
Reglan-10 (Cosme farma laboratories Ltd., Karnataka, India);
and one brand of injection containing 10 mg MCP per 2 ml,
S66 O. Zenita Devi et al.perinorm (IPCA Laboratories Ltd., Mumbai, India) used in
the investigation were purchased from local commercial
sources.
A stock standard solution of pure drug equivalent
300 lg ml1 MCP was prepared in glacial acetic acid and di-
luted to get 30 lg ml1 MCP solution with the same acid. A
10% solution of vanillin was made by dissolving 10 g of vanil-
lin in 100 ml glacial acetic acid.
2.3. Procedures
2.3.1. Procedure for calibration curve
Different aliquots (0.25, 0.5, 1.0, 1.5, 2.0 and 2.5 ml) of
30 lg ml1 MCP solution were accurately transferred into a
series of 5 ml calibrated ﬂasks using a micro burette and the
total volume was adjusted to 2.5 ml by adding glacial acetic
acid. One milliliter of 0.1 M perchloric acid and 1 ml of 10%
vanillin were added, the content was mixed and made up to
the mark with glacial acetic acid. The absorbance of each solu-
tion was measured at 410 nm against a reagent blank.
2.3.2. Procedure for spiked human urine
A 50 ml volume of MCP – free human urine taken in a 125 ml
separating funnel was spiked with 2.5 mg MCP. Ten milliliters
of 1 M NaOH was added, mixed and kept aside for 3 min.
Then, 25 ml of ethyl acetate was added, shaken well for about
15 min and the upper organic layer was collected in a beaker
containing anhydrous sodium sulfate. The water-free organic
layer was transferred into a dry beaker and solvent removed
by evaporation on a hot water bath. The dry residue was dis-
solved in glacial acetic acid and transferred into a 25 ml cali-
brated ﬂask, and diluted to the mark with the same acid.
The resulting solution equivalent to 100 lg ml1 MCP was di-
luted with the same acid to get 30 lg ml1 MCP and analyzed
by following the procedure described above.Scheme 1 Probable2.3.3. Procedure for tablets
Twenty tablets were powdered and mixed thoroughly. An
amount of powder equivalent to 15 mg of MCP was weighed
into a 50 ml calibrated ﬂask, 30 ml of glacial acetic acid was
added and the mixture was shaken for 20 min; then the volume
was made up to the mark with the same acid, mixed well and
ﬁltered using Whatman No. 42 ﬁlter paper. The resulting tab-
let extract (300 lg ml1 in MCP) was diluted appropriately
with the same acid to get a working concentration of
30 lg ml1 MCP and subjected to analysis following the proce-
dure described above.
2.3.4. Procedure for injection
The contents of ten injection tubes were pooled in a dry beaker
and mixed. An aliquot containing 15 mg of MCP was mea-
sured accurately and transferred to a 50 ml calibrated ﬂask
and diluted with glacial acetic acid. The resulting solution
(300 lg ml1 in MCP) was further diluted to get 30 lg ml1
MCP and then subjected to analysis following the procedure
described above.
2.3.5. Placebo blank and synthetic mixture analyses
A placebo blank of the composition: talc (20 mg), starch
(15 mg), acacia (15 mg), methyl cellulose (20 mg), sodium cit-
rate (15 mg), magnesium stearate (15 mg) and sodium alginate
(25 mg), was transferred to a 50 ml calibration ﬂask and its
solution was prepared as described under ‘‘procedure for
tablets’’ and then subjected to analysis using the procedure
described above.
For synthetic mixture analysis, to the placebo blank of the
composition described above, 1.5 mg of MCP was added and
homogenized, transferred to a 50 ml calibrated ﬂask and the
solution was prepared as described under ‘‘procedure for
tablets’’, and then subjected to analysis by the procedure de-
scribed above. The analysis was used to study the interferencesreaction scheme.
Sensitive spectrophotometric determination S67of excipients such as talc, starch, acacia, methyl cellulose, so-
dium citrate, magnesium stearate and sodium alginate.
3. Results and discussion
3.1. Chemistry
The Schiff’s base linkages are known to form easily by a con-
densation reaction of aromatic amine with an aldehydic group
at the terminus of an organic compound (Ki and Dong, 1999).
Based on this reaction many pharmaceutical compounds con-
taining aromatic amine group have been determined (Annap-
urna et al., 2009; Adegoke and Nwoke, 2008; Siddappa
et al., 2008; Claire et al., 1947; Tehseen et al., 2005) and the
same reaction was adopted for the assay of MCP, since it con-
tains primary aromatic amine group. The proposed method
utilized vanillin which contains an aldehyde group.
The condensation reaction requires the presence of an acid
for the protonation of the carbonyl oxygen and thereby leaving
the carbonyl carbon fully positive charge. The NH2 group in
MCP donates a lone pair of electrons to the carbon present in
the carbonyl group of vanillin. Internal rearrangement thereaf-Figure 1 Absorption spectra (9 lg ml1 MCP).ter results in the formation of imine (Schiff’s base) and then
giving water and proton as by-products (Annapurna et al.,
2009). The tentative reaction scheme is shown in Scheme 1.
3.2. Spectral characteristics
As shown in Fig. 1a, the condensation product as well as the
blank absorb maximally at 340 nm. However, the maximum
difference in absorbance between the sample and blank was
observed at 410 nm as shown clearly in Fig. 1b. Hence, all
measurements were made at this wavelength against reagent
blank.
3.3. Optimization of experimental variables
Various experimental variables were optimized to achieve
maximum sensitivity.
3.3.1. Effect of vanillin
Vanillin is insoluble in water and H2SO4. Even though it is sol-
uble in methanol, there was no development of color in this
medium. In acetic acid, both vanillin and MCP were found
to dissolve and the yellow colored reaction product was also
obtained in this medium. Hence, acetic acid was used to pre-
pare vanillin and MCP solutions. The effect of vanillin on
the sensitivity of the reaction was studied by using 10% vanil-
lin and it was observed that when 1–2 ml was used, the absor-
bance readings were nearly constant; below and above this
range there was a decrease in absorbance (Fig. 2). Blank
absorption was found to increase with increasing concentra-
tion of vanillin. Hence, considering minimum blank absorp-
tion and maximum chromogen absorption, 1 ml of 10%
vanillin was used as optimum in a total volume of 10 ml.
3.3.2. Effect of acid, reaction time and color stability
In aqueous medium, MCP failed to give condensation product
with vanillin even in the presence of H2SO4. Yellow colored
product was developed only in glacial acetic acid medium,
hence, acetic acid was used as the solvating solvent. The inten-
sity of the yellow color was found to increase on addition of
concentrate H2SO4, however even the blank itself showedFigure 2 Effect of vanillin (9 lg ml1 MCP).
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Fortunately, the sensitivity and the stability of the reaction
product were enhanced in perchloric acid medium. The effect
of perchloric acid was studied by using 0.1 M perchloric acid.
The sensitivity of the color increased with increase in per-
chloric acid concentration and then decreased and blank
absorption was found to increase with increasing concentra-
tion of perchloric acid (Fig. 3). Hence, 1 ml of 0.1 M acid in
a total volume of 10 ml was ﬁxed as the optimum.
Reaction was found to be instantaneous and the colored
product remained stable for more than one day.
3.3.3. Order of addition
After optimizing all other experimental variables, further
experiments were performed to ascertain the inﬂuence of order
of addition of reactants on the color development. Maximum
sensitivity was achieved when perchloric acid was added before
adding vanillin as shown in Fig. 4. Hence, the method was per-
formed in the order: MCP + perchloric acid + vanillin.Figure 3 Effect of perchloric acid (9 lg ml1 MCP).
Figure 4 Effect of order of reactants (9 lg ml1 MCP).3.4. Method validation
3.4.1. Analytical parameters
A linear relation was found to exist between absorbance and
the concentration of MCP in the range (1.5–15.0) lg ml1
(Fig. 5). The calibration graph is described by the equation:
Y ¼ aþ b X
(where Y is the absorbance, a is the intercept, b is the slope and
X is the concentration in lg ml1) obtained by the method of
least squares. Correlation coefﬁcient, intercept and slope for
the calibration data are summarized in Table 1. Sensitivity
parameters such as apparent molar absorptivity and Sandell’s
sensitivity values, the limits of detection and quantiﬁcation cal-
culated as per the current ICH guidelines (International Con-
ference on Harmonization, 1996) are compiled in Table 1 and
are indicative of the excellent sensitivity of the method. The
limits of detection (LOD) and quantiﬁcation (LOQ) were cal-
culated according to the same guidelines using the formulae:
LOD ¼ 3:3r=b and LOQ ¼ 10r=b
where r is the standard deviation of ﬁve reagent blank determi-
nations and b is the slope of the calibration curve.Table 1 Sensitivity and regression parameters.
Parameter Proposed method
kmax (nm) 410
Linear range (lg ml1) 1.5–15.0
Molar absorptivity (e) l mol1 cm1 1.89 · 104
Sandell sensitivitya (lg cm2) 0.019
Limit of detection (LOD) (lg ml1) 0.51
Limit of quantiﬁcation (LOQ) (lg ml1) 1.55
Regression equation Yb
Intercept (a) 0.008
Slope (b) 0.053
Standard deviation of a (Sa) 0.035
Standard deviation of b (Sb) 0.003
Regression coeﬃcient (r) 0.999
a Limit of determination as the weight in lg ml1 of solution,
which corresponds to an absorbance of A= 0.001 measured in a
cuvette of cross-sectional area 1 cm2 and l = 1 cm.
b Y= a+ b X, where Y is the absorbance, X is concentration in
lg ml1, a is intercept, b is slope.
Figure 5 Calibration curve.
Table 2 Evaluation of intra-day and inter-day accuracy and precision.
MCP taken (lg ml1) Intra-day accuracy and precision Inter-day accuracy and precision
MCP found % RE % RSD MCP found % RE % RSD
6.0 6.06 1.00 1.02 6.09 1.50 1.12
9.0 9.08 0.89 0.99 9.13 1.44 1.24
12.0 12.05 0.417 1.08 12.15 1.25 1.16
RE: relative error and RSD: relative standard deviation.
Table 3 Robustness and ruggedness expressed as intermediate precision (% RSD).
MCP taken
(lg ml1)
Method robustness Method ruggedness
Parameters altered
Perchloric acida (0.1 M) ml
RSD, % (n= 3)
Vanillinb (10%) ml,
RSD, % (n= 3)
Inter-analysts’
RSD, % (n= 4)
Inter-instruments’
RSD, % (n= 3)
6.0 1.01 1.07 0.99 1.29
9.0 1.13 1.17 1.04 1.32
12.0 1.05 0.98 1.08 1.37
a Perchloric acid.
B Vanillin volumes used were 0.8, 1.0 and 1.2 ml.
Table 4 Recovery of the drug from synthetic mixture.
MCP in synthetic
mixture taken (lg ml1)
MCP recovereda
(percent ± SD)
6.0 95.38 ± 0.66
9.0 96.18 ± 0.71
12.0 96.75 ± 0.69
a Mean value of ﬁve determinations.
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The accuracy and precision of the method were evaluated by
performing seven replicate analyses on pure drug solution at
three different concentration levels (within the working range).
The relative error (%), an indicator of accuracy was 61.50 and
within day precision, also called the repeatability, expressed asTable 5 Results of analysis of tablets and injection by the propose
Tablet/injection
brand name
Label claim,
(mg/tablet)
MCP in tablet/injection
taken (lg ml1)
MCP
Refere
metho
Perinorm-10b 10 6.00 5.95 ±
Raglan-10c 10 6.00 6.01 ±
Injection perinorm-10b 10 6.00 6.07 ±
The value of t (tabulated) at 95% conﬁdence level and for four degrees o
The value of F (tabulated) at 95% conﬁdence level and for four degrees
a Mean value of ﬁve determinations.
b IPCA Laboratories Ltd., Mumbai, India.
c Cosme farma laboratories Ltd., Karnataka, India.relative standard deviation (RSD %) was 61.24 indicating
high accuracy and repeatability of the method. The results of
the study are given in Table 2. The reproducibility of the meth-
od also known as the intra-day precision was evaluated by per-
forming replicate analyses on pure drug solution at three levels
over a period of ﬁve days, preparing all solutions afresh. The
intra-day RSD values were less than 2% reﬂecting the useful-
ness of the method in routine analysis.
3.4.3. Robustness and ruggedness
Method robustness was tested by making small incremental
changes in perchloric acid and vanillin concentrations. To
check the ruggedness, analysis was performed by four different
analysts and on three different spectrophotometers by the
same analyst. The robustness and the ruggedness were checked
at three different drug levels. The intermediate precision,d method.
founda (lg ml1) ± SD Founda (percent of label claim ± SD)
nce
d
Proposed
method
Reference
method
Proposed
method
0.04 5.90 ± 0.04 99.18 ± 0.68 98.27 ± 0.73
t= 2.04
F= 1.15
0.04 6.08 ± 0.05 100.17 ± 0.63 101.3 ± 0.76
t= 1.63
F= 1.46
0.04 6.12 ± 0.04 101.12 ± 0.59 102.1 ± 0.65
t= 2.49
F= 1.21
f freedom is 2.77.
of freedom is 6.39.
Table 6 Accuracy assessment by recovery experiments.
Tablet studied MCP in tablet (lg ml1) Pure MCP added (lg ml1) Total found (lg ml1) Pure MCP recovereda
Percent ± SD
Raglan-10 6.08 3.0 9.13 101.67 ± 0.73
6.08 6.0 12.05 99.50 ± 0.85
6.08 9.0 14.92 98.22 ± 0.77
a Mean value of three measurements.
S70 O. Zenita Devi et al.expressed as percent RSD, which is a measure of robustness
and ruggedness was within the acceptable limits as shown in
the Table 3.
3.4.4. Effect of interferences
The effect of interferences was tested by placebo blank and
synthetic mixture analyses. A convenient aliquot of the pla-
cebo blank solution was subjected to analysis according to
the recommended procedure. There was no interference by
the inactive ingredients as indicated by the near blank
absorbance.
The analysis of synthetic mixture solution yielded percent
recoveries which ranged between 95.38 and 96.75 with stan-
dard deviation of 0.66–0.71. The results of this study are pre-
sented in Table 4 indicating that the inactive ingredients did
not interfere in the assay.
3.4.5. Application to the analysis of spiked urine sample, tablets
and injection
The proposed method was successfully applied to the determi-
nation of MCP in spiked urine sample. The percent recovery of
pure MCP added was 86.37 with standard deviation of 0.87
(n= 5). In order to evaluate the analytical applicability of
the proposed method to the quantiﬁcation of MCP in commer-
cial tablets and injection, the results obtained by the proposed
method were compared to those of the reference method (Brit-
ish Pharmacopoeia, 2009) by applying Student’s t-test for
accuracy and F-test for precision. In reference method,
0.2500 g of MCP was dissolved in 5.0 ml of 0.01 M HCl and
50 ml of alcohol; and the resulting solution was titrated with
0.1 M NaOH to potentiometric end point detection. The re-
sults (Table 5) show that the Student’s t- and F-values at
95% conﬁdence level are less than the theoretical values, indi-
cating that there is a good agreement between the results ob-
tained by the proposed method and the reference method
with respect to accuracy and precision.
3.4.6. Recovery studies
The accuracy and validity of the proposed method were fur-
ther ascertained by performing recovery studies. Pre-analyzed
tablet powder was spiked with pure MCP at three levels (50%,
100% and 150% of that found in tablet powder) and the total
was determined by the proposed method. The percent recovery
of pure MCP added was in the range of 98.22–101.67% with
standard deviation of 0.73–0.85 (Table 6) indicating that the
recovery was good, and that the co formulated substance did
not interfere in the determination.
4. Conclusions
A simple, sensitive and rapid method for the determination
of MCP in its dosage forms and in spiked human urine is de-scribed, involving the use of vanillin as a chromogenic agent.
The method is rapid and less tedious than many reported
spectrophotometric methods. The present method can be ap-
plied at ambient temperature, color development is instanta-
neous and does not require strict pH control or tedious
liquid-liquid extraction step. The method employs inexpen-
sive and easily available chemicals and instrument. As most
relevant features of the method, high sensitivity and a wide
linear dynamic range compared to many existing methods
can be emphasized. The color formed is highly stable leading
to very precise results. An addition feature of the method is
its applicability to determine the drug in spiked human urine
after due sample treatment. These advantages make the
method a valuable alternative to many existing methods for
the determination of MCP in pharmaceuticals and body
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